Last reviewed · How we verify
Ferrostrane (SODIUM FEREDETATE)
Sodium Fedetate (Ferrostrane) is a marketed drug that binds to iron and facilitates its excretion, positioning it in the iron management market. A key strength of Ferrostrane is its established market presence, with a key composition patent expiring in 2028. The primary risk is competition from same-class drugs, including sucroferric oxyhydroxide and ferric maltol, the latter of which is patent-protected until October 23, 2035.
At a glance
| Generic name | SODIUM FEREDETATE |
|---|---|
| Drug class | sodium feredetate |
| Modality | Small molecule |
| Therapeutic area | Nephrology |
| Phase | FDA-approved |
Approved indications
Common side effects
Drug interactions
- dolutegravir
- enoxacin
- levodopa
- levofloxacin
- levothyroxine sodium
- lomefloxacin
- minocycline
- moxifloxacin
- mycophenolate mofetil
- norfloxacin
- ofloxacin
Key clinical trials
- Prebiotic GOS and Lactoferrin With Iron Supplements (NA)
- Comparison of the Rate of Preoperative Haemoglobin After Administration of Epoetin Alpha Associated With an Oral Medical Supplementation Versus Intravenous Before Surgery of Craniosynostosis at the Child (NA)
- Iron-fortified Lentils to Improve Iron (Fe) Status in Bangladesh (NA)
- Iron and Prebiotics Fortification in Kenyan Infants (NA)
- Probing the Synergistic Effect of Pre-Biotics & Iron Fortificants in Anemic Subjects (PHASE1,PHASE2)
- Iron Absorption From a Micronutrient Powder Containing Galacto-oligosaccharides (GOS) (NA)
- Effect of Timing of Micronutrient Powder Consumption on Iron Absorption in Infants (NA)
- Thiamin Fortified Fish Sauce as a Means of Combating Infantile Beriberi in Rural Cambodia (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ferrostrane CI brief — competitive landscape report
- Ferrostrane updates RSS · CI watch RSS